GI Map Test Opportunistic Bacteria and Dysbiosis

When your GI MAP test shows high levels of opportunistic bacteria, it is pointing to dysbiosis, an imbalance in the gut microbiome that can drive digestive symptoms, systemic inflammation, skin problems, joint pain, hormonal disruption, and mood changes. 

The GI Map opportunistic bacteria are considered normal at low levels, but when they overgrow they can disrupt the balance of the entire gut ecosystem and, in some cases, escape the gut entirely and contribute to a wide range of health conditions.

This article explains what dysbiosis is, how the GI-MAP identifies and categorizes opportunistic bacteria, the autoimmune and inflammatory connections that make this section of the test so clinically important, and what treatment strategies help restore balance.

Key Takeaways

• Opportunistic bacteria are normal at low levels but overgrowth can cause digestive symptoms, inflammation, skin problems, joint pain, and mood changes.
• The GI-MAP test identifies three dysbiosis patterns: insufficiency dysbiosis, inflammatory dysbiosis, and digestive dysfunction dysbiosis. Understanding which pattern is dominant shapes the treatment approach.
• The opportunistic bacteria are grouped into three categories: dysbiotic/overgrowth bacteria, commensal/overgrowth microbes, and inflammatory/autoimmune-related bacteria.
• Several of these organisms are directly linked to autoimmune conditions including rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, and systemic sclerosis.
• Some organisms produce histamine, hydrogen sulfide, or LPS, which explains symptom patterns like histamine intolerance, MCAS, bloating, and systemic inflammation.
• Treatment goes beyond supplements. Diet, stress management, sleep, and prebiotics are foundational. Supplements should be introduced in the right order, starting with the most important finding first.

What Is Dysbiosis?

Dysbiosis refers to an imbalance in the gut microbiome, and the GI-MAP test identifies three distinct patterns, each with a different clinical picture and treatment priority.

1. Insufficiency dysbiosis This pattern is characterized by low levels of beneficial commensal and keystone bacteria such as Bifidobacterium, Lactobacillus, Akkermansia muciniphila, Faecalibacterium prausnitzii, and Roseburia spp. 

When these bacteria are depleted, gut barrier integrity and mucosal immunity suffer, and the protective environment that normally keeps opportunistic bacteria in check weakens. Secretory IgA is often low in this pattern, and zonulin may be elevated. This is common in autoimmune, allergic, and chronic inflammatory conditions.

2. Inflammatory dysbiosis This pattern involves moderate to high levels of specific pathogens and opportunistic microbes that directly promote inflammation and increase intestinal permeability. 

Many of the bacteria involved are gram-negative bacteria belonging to the Proteobacteria phylum, which produce lipopolysaccharide (LPS), a potent activator of the immune system. Calprotectin is often elevated, or mildly elevated in this pattern, alongside eosinophil activation protein and sometimes zonulin.

3. Digestive dysfunction dysbiosis This pattern develops when impaired digestion, particularly low stomach acid (hypochlorhydria), insufficient bile acids, or pancreatic insufficiency, creates conditions where bacteria that should remain in the colon migrate upward, and where undigested food substrates fuel overgrowth. 

Elastase-1 is typically low in this pattern, and it is the most common underlying driver of SIBO. It is frequently present alongside H. pylori. There can also be an imbalance in the bile acids on the StoolOMX test.

Causes of Dysbiosis

In practice, these patterns often overlap, and identifying which is dominant is a key part of interpreting the test correctly and choosing the correct treatment plan.

Overgrowth can occur when the commensal bacteria are impaired by poor diet, antibiotic use, parasitic infection, food poisoning, chronic stress, or a weakened immune system. 

When intestinal permeability is also present, these microbes can escape the gut lumen and trigger systemic infections and inflammatory responses throughout the body. For many people, this overgrowth is the main driver of their symptoms.

What Symptoms Does Dysbiosis Cause?

Many people have mild dysbiosis without realizing it. It is usually when things become significantly out of balance due to diet, chronic stress, infection, or repeated antibiotic use that symptoms become obvious.

Physical symptoms of dysbiosis:

• Bloating and excess gas
• Constipation or diarrhea
• Acid reflux and heartburn
• Stomach pain and cramping
• Reacting to foods that were previously tolerated
• Skin problems including acne, rashes, eczema, and psoriasis
• Aching joints
• Fatigue

Mental and emotional symptoms of dysbiosis:

• Anxiety
• Depression
• Brain fog
• Poor memory and concentration
• ADHD or ADD presentations

The Three Categories of Opportunistic Bacteria on the GI-MAP

The 2025 GI-MAP organizes opportunistic bacteria into three sub-groups. Each group has somewhat different clinical implications and treatment priorities, which is why the categorization is useful when building a treatment plan.

Category 1: Dysbiotic and Overgrowth Bacteria

These organisms tend to overgrow when digestive function is impaired or when the beneficial bacteria that normally keep them in check have been depleted.

Bacillus spp.

Bacillus spp. is a group of gram-positive bacteria in the Firmicutes phylum. Some strains are used as probiotics, and a low level of Bacillus is considered normal and most people will have it present. It only becomes clinically significant at high levels, where it typically points to impaired digestive function, SIBO, or constipation.

Related article: SIBO Guide — How to Eliminate IBS

Enterococcus faecalis and Enterococcus faecium

These gram-positive bacteria in the Firmicutes phylum become problematic when they overgrow. Elevated levels commonly reflect low stomach acid, proton pump inhibitor (PPI) use, compromised digestive function, SIBO, or constipation. Their natural resistance to many antibiotics can make overgrowth persistent and complicate treatment strategies.

Morganella spp.

Morganella belongs to the Proteobacteria phylum and is one of the most clinically important organisms on this section of the test for patients with histamine-related symptoms. It is a significant histamine producer, and elevated levels are commonly associated with intestinal inflammation and diarrhea. For patients with histamine intolerance or mast cell activation syndrome (MCAS), Morganella overgrowth can be a direct driver of symptoms. See the histamine producers section below for the full list of histamine-producing organisms on the panel.

Pseudomonas spp. and Pseudomonas aeruginosa

Pseudomonas is a gram-negative bacterium in the Proteobacteria phylum. At high levels it indicates intestinal inflammatory activity and can cause abdominal cramping and loose stools. Certain strains of P. aeruginosa produce LPS toxins that damage cellular structures and amplify systemic inflammation. Pseudomonas is also both a histamine producer and a mast cell-activating bacterium, making it particularly relevant for patients with allergic or inflammatory presentations.

Staphylococcus spp. and Staphylococcus aureus

Staphylococcus is a gram-positive bacterium in the Firmicutes phylum. Elevated levels reflect reduced digestive capacity and intestinal inflammatory activity. Toxin-producing strains can aggravate these issues, contributing to diarrhea and loose stools. S. aureus is also a mast cell-activating bacterium, relevant in patients with food sensitivities and allergic presentations.

Streptococcus spp.

Streptococcus colonizes skin and mucous membranes throughout the body. In the gut, elevated levels typically arise from low stomach acid, prolonged PPI use, reduced digestive capacity, SIBO, or constipation. High concentrations are associated with intestinal inflammatory activity and can cause loose stools.

Category 2: Commensal and Overgrowth Microbes

These organisms are present in the healthy gut at normal levels but become problematic in excess, particularly in the context of digestive dysfunction.

Desulfovibrio spp.

Desulfovibrio is a gram-negative sulfate-reducing bacterium that produces hydrogen sulfide (H2S) as a metabolic byproduct. At low concentrations, hydrogen sulfide has beneficial cell-signaling functions. At higher concentrations it becomes toxic to the gut lining, contributes to inflammation, and is a common cause of foul-smelling gas. Desulfovibrio is one of the primary hydrogen sulfide producers on the GI-MAP panel.

Methanobacteriaceae (family)

This family of archaea-like microbes produces methane through fermentation of carbohydrates. At normal levels they support short-chain fatty acid production by beneficial bacteria. High levels are strongly linked to chronic constipation and methane-dominant SIBO, where methane slows intestinal transit. Low levels can indicate reduced short-chain fatty acid production and may be associated with inflammation.

Category 3: Inflammatory and Autoimmune-Related Bacteria

This is the most clinically significant sub-group for patients with chronic inflammatory conditions, autoimmune disease, and joint problems. Several of these organisms have well-documented associations with specific autoimmune conditions, and their elevated presence on the GI-MAP test can help explain why a patient’s autoimmune condition developed or is not resolving despite conventional treatment.

Citrobacter spp. and Citrobacter freundii

Citrobacter belongs to the Proteobacteria phylum. Elevated levels indicate increased intestinal inflammatory activity. Citrobacter freundii is also a histamine producer and hydrogen sulfide producer, and has associations with rheumatoid arthritis.

Klebsiella spp. and Klebsiella pneumoniae

Klebsiella is a gram-negative bacterium commonly found in the oral and respiratory tracts. At elevated levels in the intestine it can cause diarrhea, gas, abdominal pain, and bloating, and commonly overgrows after long-term antibiotic use. Klebsiella produces histamine and LPS, both of which drive gut and systemic inflammation. Its autoimmune associations are among the most significant of any organism on this panel: Klebsiella pneumoniae is linked to Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and reactive arthritis.

Mycobacterium avium subsp. paratuberculosis (MAP)

MAP is a bacterial species in the Actinobacteria phylum. While it is not commonly detected at high levels on the GI-MAP, when it is present at elevated levels it is a significant clinical marker. Higher levels have been associated with Crohn’s disease, rheumatoid arthritis, Type 1 diabetes, and possibly psoriasis. For patients with these conditions or a family history of them, MAP is worth paying close attention to.

Proteus spp. and Proteus mirabilis

Proteus belongs to the Proteobacteria phylum. Elevated levels indicate intestinal inflammatory activity and can contribute to loose stools or diarrhea. Pets and wild animals are a common source of exposure. Proteus mirabilis has specific documented associations with rheumatoid arthritis and spondyloarthropathies, and it is also a hydrogen sulfide producer.

Fusobacterium spp.

Fusobacterium is a gram-negative bacterium commonly found in the oral cavity that can also colonize the intestine. It is associated with inflammatory processes and autoimmune conditions including systemic sclerosis and IBD. It is commonly found at low levels on the GI-MAP test, so only elevated readings are clinically significant. Fusobacterium is also a hydrogen sulfide producer.

Prevotella spp.

Prevotella is a gram-negative species in the Bacteroidetes phylum. Low levels are usually not a problem. High levels may result from reduced digestive capacity or a high-starch diet. Prevotella copri has been specifically identified in research as a potential driver of early rheumatoid arthritis, making elevated levels relevant for patients with joint symptoms or existing autoimmune disease.

Enterobacter spp. and Escherichia spp.

Both of these gram-negative bacteria in the Proteobacteria phylum indicate increased intestinal inflammatory activity at high levels. Low levels of commensal (non-pathogenic) Escherichia spp. are actually beneficial, providing protection against pathogenic E. coli; it is significantly elevated levels that become a concern.

Autoimmune Associations: Why This Section Matters Beyond the Gut

One of the most important but least recognized aspects of this section is the direct link between specific opportunistic bacteria and autoimmune disease. When intestinal permeability is present alongside overgrowth of these organisms, bacteria or their components can escape the gut lumen and trigger or sustain immune responses at distant sites. The gut can be the origin of a disease that appears to have nothing to do with digestion.

Organism	Autoimmune Association
Citrobacter spp.	Rheumatoid arthritis
Fusobacterium spp.	Systemic sclerosis, IBD
Klebsiella spp.	Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis
M. avium subsp. paratuberculosis	Rheumatoid arthritis, Crohn’s disease, Type 1 diabetes, possibly psoriasis
Prevotella copri	Rheumatoid arthritis
Proteus spp.	Rheumatoid arthritis
Proteus mirabilis	Rheumatoid arthritis, spondyloarthropathies

For patients with autoimmune disease who have never investigated their gut microbiome, this is often a missing piece of the puzzle. Addressing underlying dysbiosis, reducing intestinal permeability, and targeting the specific organisms involved can make a meaningful difference to autoimmune symptoms alongside conventional treatment.

Gas, Histamine, and LPS Producers

Many opportunistic bacteria drive symptoms through specific metabolic activities, not just by disrupting the microbiome in general. Understanding which organisms produce what helps explain why certain patients have such distinctive symptom profiles, particularly where histamine intolerance, MCAS, bloating, or systemic inflammation are prominent features.

Histamine-Producing Bacteria

Overgrowth of these organisms can drive or worsen histamine intolerance and MCAS independently of dietary histamine intake:

• Lactobacillus spp. (certain strains)
• Morganella spp.
• Pseudomonas and Pseudomonas aeruginosa
• Citrobacter freundii
• Klebsiella and Klebsiella pneumoniae
• Proteus and Proteus mirabilis
• Enterobacter spp.
• Escherichia spp.
• Fusobacterium spp.

Hydrogen Sulfide Producers

These organisms produce H2S, which at elevated concentrations is toxic to the gut lining, impairs mitochondrial function, slows motility, and causes foul-smelling gas:

• Bacteroides fragilis
• Escherichia spp.
• Enterobacter spp.
• Desulfovibrio spp.
• Morganella spp.
• Pseudomonas aeruginosa
• Staphylococcus aureus
• Citrobacter spp. and Citrobacter freundii
• Klebsiella spp. and Klebsiella pneumoniae
• Proteus spp. and Proteus mirabilis
• Fusobacterium spp.

LPS (Lipopolysaccharide) Producers

LPS from gram-negative bacteria is one of the most potent activators of systemic inflammation. When it enters the bloodstream through a leaky gut, it drives metabolic endotoxemia, insulin resistance, and chronic immune activation:

• Escherichia spp.
• Enterobacter spp.
• Morganella spp.
• Pseudomonas spp. and Pseudomonas aeruginosa
• Citrobacter spp. and Citrobacter freundii
• Klebsiella spp. and Klebsiella pneumoniae
• Proteus and Proteus mirabilis

Treatment Options for Dysbiosis

When assessing the GI-MAP test it is important not to look at each marker in isolation. The test needs to be read as a whole, alongside each person’s signs and symptoms, to determine the right treatment sequence. Supplements can help and are often needed to restore balance, but the most important foundation is diet and lifestyle.

Many people take great supplements but often do things in the wrong order and don’t get results, this is why interpreting the results correctly is important.

Diet

For patients with significant overgrowth of opportunistic bacteria, a short-term low FODMAP diet is often a useful starting point. This is typically maintained for around 3 to 4 weeks, until symptoms such as gas, bloating, constipation, and diarrhea improve. Once symptoms stabilize, foods are reintroduced gradually. It is important that any restrictive diet is used for as short a time as necessary, because dietary diversity is critical for microbiome recovery and long-term gut health.

Sleep and Stress

Poor sleep creates physical and emotional stress on the body, and chronic stress from work, relationships, or unresolved trauma directly impairs gut health. Stress suppresses secretory IgA (the gut’s primary immune defence) and slows digestive function, both of which enable opportunistic overgrowth. These are not optional add-ons to a treatment protocol,  they can be central to whether treatment works.

Supplements

Treatment should always be individualized. There is no single protocol that addresses every pattern of gut microbiome imbalance, and taking too many supplements at once makes it impossible to know what is helping or identify the cause of any side effects.

A practical approach is to start with 4 to 5 targeted supplements and address things in the right order. If H. pylori is present, it often needs to be treated first, as it impairs stomach acid and creates downstream conditions that perpetuate dysbiosis. If elastase-1 is low or SIgA is suppressed, supporting digestive function and mucosal immunity before targeting opportunistic bacteria directly tends to produce better outcomes.

Related article: Tips to Test and Balance SIgA

Useful antimicrobial herbs for opportunistic overgrowth include berberine, caprylic acid, garlic, oil of oregano, uva ursi, and olive leaf extract. The specific combination depends on which organisms are elevated and the overall pattern of the test.

Treatment is not just about reducing unwanted bacteria. Rebuilding beneficial bacteria through probiotics, prebiotics, and fermented foods is an equally important part of any protocol, and is what provides lasting results rather than temporary symptom relief.

Retesting

I recommend retesting 3 to 6 months after completing a treatment protocol, testing too soon does not give enough time for the microbiome to rebalance. This confirms which pathogens have cleared, assesses recovery of beneficial bacteria, and identifies what still needs attention. Retesting is particularly important when autoimmune-related organisms were elevated or when antibiotic resistance was a factor.

Summary

The opportunistic bacteria section of the GI-MAP is one of the most important parts of the report, and it is frequently underappreciated when practitioners or patients focus only on obvious pathogens. These organisms exist on a spectrum from mildly disruptive to directly autoimmune-triggering, and identifying the right treatment sequence requires understanding the full picture.

The GI-MAP is mainly focused on the large intestine. It can give useful clues as to whether SIBO is contributing, but some patients will benefit from a specific SIBO breath test or a device such as the Aire 2 from Food Marble for more detailed small intestinal assessment.

Working with an experienced practitioner to interpret your GI-MAP results saves time and money in the long run by ensuring the most important findings are addressed first, and that treatment is targeted rather than generic.

Still Not Sure What Is Driving Your Symptoms?

If you have a GI-MAP result you are trying to make sense of, or you are considering testing and are not sure where to start, a one-on-one consultation can help you understand what the results mean for your situation and what to do about them.

Frequently Asked Questions

For a comprehensive overview of everything the GI-MAP tests for, visit the Complete Guide to the GI-MAP Test. To order the test, visit the GI-MAP order page, or contact us to discuss which test is right for your situation.